Determination of Alendronate Sodium by Box-Behnken Statistical Design

被引:15
作者
Sultana, Shaheen [1 ]
Talegaonkar, Sushma [1 ]
Mittal, Gaurav [2 ]
Bhatnagar, Aseem [2 ]
Ahmad, Farhan J. [1 ]
机构
[1] Fac Pharm, Dept Pharmaceut, Delhi, India
[2] DRDO, Inst Nucl Med & Allied Sci, Dept Nucl Med, New Delhi, India
关键词
Column Liquid chromatography; Box-Behnken design; Beer's law; Alendronate sodium; Ninhydrin; PERFORMANCE LIQUID-CHROMATOGRAPHY; AUTOMATED PRECOLUMN DERIVATIZATION; HUMAN PLASMA; FLUORESCENCE; URINE; ACID;
D O I
10.1365/s10337-010-1656-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Spectrophotometric and LC methods have been developed and validated for the analysis of alendronate sodium in tablet dosage forms. Methods were based on reaction of the primary amino group of alendronate with ninhydrin reagent in methanolic solution of sodium bicarbonate. The condensed product exhibited UV absorption maximum at 569 nm whereas neither the reagents nor the analyte had any UV absorption. A Box-Behnken statistical design was employed to study the effect of independent variables, ninhydrin (X (1) ), NaHCO3 (X (2) ) and drug concentration (X (3) ) on dependent variable, absorption via spectrophotometer. From the point prediction tool of design software, it was observed that ninhydrin (0.26%) and NaHCO3 (0.048 mol L-1) produced maximum absorption. These optimized parameters were then selected for method validation. The methods obeyed Beer's law over a selected concentration range with good correlation co-efficient (> 0.99). The limit of detection and limit of quantification were 4.5 and 13.75 mu g mL(-1) by spectroscopy, and 87 and 263 ng mL(-1) by LC, respectively. Accuracy, precision and % recovery were satisfactory for the proposed method. The method was highly feasible and reproducible for determination of alendronate sodium in bulk powder and pharmaceutical dosage form.
引用
收藏
页码:321 / 326
页数:6
相关论文
共 12 条
[1]   Colorimetric determination of gabapentin in pharmaceutical formulation [J].
Abdellatef, HE ;
Khalil, HM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (01) :209-214
[2]   Spectroscopic and HPLC methods for the determination of alendronate in tablets and urine [J].
Al Deeb, SK ;
Hamdan, II ;
Al Najjar, SM .
TALANTA, 2004, 64 (03) :695-702
[3]   THE DETERMINATION OF 4-AMINO-1-HYDROXYBUTANE-1,1-DIPHOSPHONIC ACID MONOSODIUM SALT TRIHYDRATE IN PHARMACEUTICAL DOSAGE FORMS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
DEMARCO, JD ;
BIFFAR, SE ;
REED, DG ;
BROOKS, MA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (12) :1719-1727
[4]  
FRITZ F, 1995, SPOT TESTS ORGANIC A, P493
[5]   DETERMINATION OF 4-AMINO-1-HYDROXYBUTANE-1,1-BISPHOSPHONIC ACID IN URINE BY AUTOMATED PRECOLUMN DERIVATIZATION WITH 2,3-NAPHTHALENE DICARBOXYALDEHYDE AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
KLINE, WF ;
MATUSZEWSKI, BK ;
BAYNE, WF .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 534 :139-149
[6]   IMPROVED DETERMINATION OF THE BISPHOSPHONATE ALENDRONATE IN HUMAN PLASMA AND URINE BY AUTOMATED PRECOLUMN DERIVATIZATION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE AND ELECTROCHEMICAL DETECTION [J].
KLINE, WF ;
MATUSZEWSKI, BK .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 583 (02) :183-193
[7]   A simple and rapid high-performance liquid chromatography method for determination of alendronate sodium in beagle dog plasma with application to preclinical pharmacokinetic study [J].
Meng, Jian ;
Meng, Qiang ;
Zheng, Liangyuan .
BIOMEDICAL CHROMATOGRAPHY, 2010, 24 (02) :169-173
[8]   The utilization of copper(II) phosphate for the anodic stripping voltammetric assay of alendronate sodium, desferrioxamine mesylate and lisinopril [J].
Razak, OA ;
Belal, SF ;
Bedair, MM ;
Haggag, RS .
TALANTA, 2003, 59 (05) :1061-1069
[9]  
RUSSELL R, 1997, BONE, V25, P97
[10]   Bisphosphonates: Mode of action and pharmacology [J].
Russell, R. Graham G. .
PEDIATRICS, 2007, 119 :S150-S162